MarketCapTrends
ANIP

Ani Pharmaceuticals Inc. (ANIP)

NASDAQ · Healthcare

Ani Pharmaceuticals Inc. annual/quarterly long term debt history from 2014 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • Ani Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2025 were 291.8M, a 5.59% decrease year-over-year.
  • Ani Pharmaceuticals Inc. long term debt for 2025 were 291.8M, a 5.59% decrease from 2024.
  • Ani Pharmaceuticals Inc. long term debt for 2024 were 309.1M, a 8.53% increase from 2023.
  • Ani Pharmaceuticals Inc. long term debt for 2023 were 284.8M, a 0.30% decrease from 2022.
  • Ani Pharmaceuticals Inc. long term debt for 2022 were 285.7M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Ani Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $)
2025$292
2024$309
2023$285
2022$286
2021$287
2020$172
2019$176
2018$67
2017$128
2016$121
2015$113
2014$107
Ani Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $)
2025-12-31$292
2024-12-31$309
2023-12-31$285
2022-12-31$286
2021-12-31$287
2020-12-31$172
2019-12-31$176
2018-12-31$67
2017-12-31$128
2016-12-31$121
2015-12-31$113
2014-12-31$107

Ani Pharmaceuticals Inc. Long Term Debt — FAQ

Ani Pharmaceuticals Inc. (ANIP) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ANIP's long term debt history?

The chart and table above show Ani Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.